AstraZeneca likely to run additional global vaccine test, CEO Pascal Soriot says

“Now that we’ve found what looks like a better efficacy we have to validate this, so we need to do an additional study,” CEO Pascal Soriot said in his first interview since the data were released. It will probably be another “international study, but this one could be faster because we know the efficacy is high so we need a smaller number of patients.”

Source: The Economic Times - November 26, 2020 Category: Consumer Health News Source Type: news